Review articleBright light therapy for nonseasonal depression: Meta-analysis of clinical trials
Introduction
The description of light therapy as a treatment option was first mentioned in association with the syndrome of seasonal affective disorder/winter type (SAD) (Rosenthal et al., 1984). This syndrome is characterized by episodes of major depression which follow a seasonal pattern, mostly occurring in winter and fall with full remission during spring and summer seasons (Even et al., 2008). Since these seasonal changes in mood are mediated by alterations in melatonin, which is a central hormone secreted by the pineal gland in a circadian pattern and regulated by the light-dark cycle (day and night) and the seasonal cycle, the exposure to bright light was proposed as the treatment of choice (Lewy et al., 1980). Several mechanisms were suggested to explain how bright light therapy (BLT) may alleviate depressive symptoms. First, early animal studies showed that light is able to shift the circadian and seasonal rhythms (De Coursey, 1960, Pittendrigh, 1960), thus modulating the chronobiological cycle (Murray et al., 2005). Second, it is believed that extending the duration of daylight during the winter season will modulate these rhythms by regulating the master clock, the suprachiasmatic nucleus (SCN), resulting in an antidepressant effect (Rosenthal et al., 1984). Afterwards, these hypotheses were supplanted by the phase shift hypothesis which attributed depression in SAD patients to phase delay in circadian rhythms relative to the sleep/wake cycles, with a smaller subgroup of these patients becoming depressed due to a phase advance (Lewy et al., 1987). However, the exact mechanism of action of BLT in the treatment of depression remains unclear (Pail et al., 2011).
The interest in BLT has expanded beyond SAD; many clinical trials reported conflicting conclusions about whether BLT is effective as a treatment modality in nonseasonal depression (Even et al., 2008). Earlier meta-analyses of trials on the efficacy of BLT revealed that it is efficacious in the treatment of the seasonal type of depression (Golden et al., 2005, Martensson et al., 2015). However, its application in nonseasonal depression is less clear as recent reviews have refrained from meta-analytically pooling data, due to the heterogeneity of studies (Even et al., 2008, Martensson et al., 2015). Because new trials on the efficacy of BLT in nonseasonal depression have been recently published, we decided to conduct a meta-analysis in order to assess the clinical efficacy of such treatment in nonseasonal depression.
Section snippets
Literature search
This systematic review protocol was registered at Prospero International Prospective Register of Systematic Reviews (Registration ID= CRD42015032297). We have systematically searched the following online databases: Pubmed; Scopus; PsycINFO; Evidence Based Medicine (EBM) Guidelines; JAMA evidence and the Cochrane library. Several MeSH terms were used to identify relevant literature: bright light therapy OR phototherapy AND depression OR major depressive disorders OR nonseasonal depression AND
Description of the included studies
Of the 1840 studies identified during the initial stage of the literature search, 41 full-text articles were retrieved and evaluated based on the selection criteria. Nine trials met the inclusion criteria. Fig. 1 depicts the selection process of the included trials. Data were extracted and pooled from 9 clinical trials (Corral et al., 2007, Dauphinais et al., 2012, Goel et al., 2005, Kripke et al., 1992, Lam et al., 2015, Lieverse et al., 2011, Mackert et al., 1991, Martiny et al., 2005,
Main findings and implications
In this meta-analysis, we included 9 clinical trials with a total of 419 patients enrolled in the intervention and control arms. The result of the analysis revealed that BLT significantly improved depressive symptoms in patients with nonseasonal depression. The leave-one-out sensitivity analysis showed that the efficacy of BLT on depression is robust and consistent, irrespective of the individual effect of any trial. Our results are consistent with previous reviews; Tuunainen et al. (2004)
References (38)
- et al.
Bright light exposure during acute tryptophan depletion prevents a lowering of mood in mildly seasonal women
Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol.
(2008) - et al.
Serum concentrations of thyroid hormones in patients with nonseasonal affective disorders during treatment with bright and dim light
Biol. Psychiatry
(1996) - et al.
Controlled trial of safety and efficacy of bright light therapy vs. negative air ions in patients with bipolar depression
Psychiatry Res.
(2012) - et al.
Effects of phototherapy on non-seasonal unipolar and bipolar depressive spectrum disorders
J. Affect. Disord.
(1991) - et al.
Meta-analysis in clinical trials
Control. Clin. Trials
(1986) - et al.
Efficacy of light therapy in nonseasonal depression: a systematic review
J. Affect. Disord.
(2008) - et al.
Sleep deprivation as a predictor of response to light therapy in major depression
J. Affect. Disord.
(2001) - et al.
Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment – neurobiological and psychometric assessment of course
J. Psychiatr. Res.
(1994) Light treatment for nonseasonal depression: speed, efficacy, and combined treatment
J. Affect. Disord.
(1998)- et al.
Controlled trial of bright light for nonseasonal major depressive disorders
Biol. Psychiatry
(1992)
Phototherapy in nonseasonal depression
Biol. Psychiatry
Bright white light therapy in depression: a critical review of the evidence
J. Affect. Disord.
Bright light therapy stabilizes the antidepressant effect of partial sleep deprivation
Biol. Psychiatry
Quality Assessment Tool for Quantitative Studies
The Hamilton Depression Rating Scale: has the gold standard become a lead weight?
Am. J. Psychiatry
Phototherapy is a useful adjunct in the treatment of depressed in-patients
Acta Psychiatr. Scand.
Morning light therapy for postpartum depression
Arch. Women's Ment. Health
Daily light sensitivity rhythm in a rodent
Science
Bias in meta-analysis detected by a simple, graphical test
BMJ Br. Med. J.
Cited by (125)
Delivery of bright light therapy within the Veterans Health Administration
2024, Journal of Affective DisordersMood Disorders in Youth: Complementary and Integrative Medicine
2023, Child and Adolescent Psychiatric Clinics of North AmericaEffectiveness of light therapy as adjunctive treatment in bipolar depression: A pilot study
2023, Journal of Affective DisordersA critical overview of systematic reviews and meta-analyses of light therapy for non-seasonal depression
2022, Psychiatry ResearchCitation Excerpt :The SRs/MAs were published between 2016 and 2020, and the number of trials in the included SRs/MAs were between 6 and 23, and trials each with sample sizes ranging from 359 to 1120 subjects. The authors of these SRs/MAs were mainly affiliated with institutions in Asia (four (Tao et al., 2020; Chang et al., 2018; Zhao et al., 2018; Bangshan et al., 2017) had authors from institutions in China, and one (Al-Karawi and Jubair, 2016) had authors from institutions in Iraq). One SR/MA (Perera et al., 2016) had authors from institutions in Canada; Five of the SRs/MAs were published in English (Tao et al., 2020; Chang et al., 2018; Zhao et al., 2018; Perera et al., 2016; Al-Karawi and Jubair, 2016) and one was in Chinese (Bangshan et al., 2017).
Sleep deprivation as a treatment for major depressive episodes: A systematic review and meta-analysis
2022, Sleep Medicine ReviewsCitation Excerpt :Of note a study in which all participants were given BLT, the addition of SD may have led to a less favourable outcome [26]. Interestingly a meta-analysis of BLT [49] in MDE showed a positive effect with 2–5 weeks of BLT. In reviewed trials the length of daily BLT therapy varied considerably ranging from 3 days [38], 1 week [39,40], 2 weeks [26],2 months [21,30] and 6 months [37].